Prices as of 2026/10/30 close
Company comparison

M3 is the largest by revenue at ¥351.4B, followed by JMDC (¥50.5B) and Medley (¥36.8B).
M3 has the highest operating margin at 20.9%, 15.1 points above the lowest, Medley (5.8%).
Revenue growth in the latest results: Medley +25.5%, M3 +23.3%, JMDC +20.9%. For next year, Medley guides for the fastest operating profit growth (+37.2%).
M3 pays the most on average (¥9.31M), ¥3.68M more than Medley (¥5.63M).
Over the past year the shares moved Medley +15.4%, M3 −13.3%, JMDC −21.2%.
Head-to-head wins16 metrics
One win per metric for the company with the best value. Metrics with no better or worse (P/E, average age, employees) are excluded.
ScaleInvestors
M3 aheadM3 3 : JMDC 0 : Medley 0
Revenue: M3 ¥351.4B / JMDC ¥50.5B / Medley ¥36.8B
ProfitabilityInvestors
M3 aheadM3 3 : JMDC 1 : Medley 0
Operating margin: M3 20.9% / JMDC 20.8% / Medley 5.8%
GrowthInvestors
Medley aheadM3 0 : JMDC 1 : Medley 3
Revenue growth (YoY): M3 +23.3% / JMDC +20.9% / Medley +25.5%
Stock & balance sheetInvestors
JMDC aheadM3 0 : JMDC 2 : Medley 1
Share price, 1 year: M3 −13.3% / JMDC −21.2% / Medley +15.4%
Pay & workforceJob seekers
EvenM3 1 : JMDC 1 : Medley 0
Average salary: M3 ¥9.31M / JMDC ¥8.23M / Medley ¥5.63M
| Metric | M3 | JMDC | Medley |
|---|---|---|---|
| Revenue | ◎¥351.4B | ¥50.5B | ¥36.8B |
| Operating profit | ◎¥73.5B | ¥10.5B | ¥2.1B |
| Net income | ◎¥49.1B | ¥6.8B | ¥975M |
| Metric | M3 | JMDC | Medley |
|---|---|---|---|
| Operating margin | ◎20.9% | 20.8% | 5.8% |
| Net margin | ◎14.0% | 13.4% | 2.7% |
| ROE | — | ◎8.4% | 5.6% |
| Revenue per employee | ◎¥499M | ¥101M | ¥24M |
| Metric | M3 | JMDC | Medley |
|---|---|---|---|
| Revenue growth (YoY) | +23.3% | +20.9% | ◎+25.5% |
| Operating profit growth (YoY) | +16.8% | ◎+20.7% | −7.6% |
| Revenue CAGRlast 5 years | +15.7% | — | — |
| Guidance: revenue growthnext FY plan | +13.8% | +19.9% | ◎+26.1% |
| Guidance: op. profit growthnext FY plan | +8.8% | +9.3% | ◎+37.2% |
| Metric | M3 | JMDC | Medley |
|---|---|---|---|
| Share price, 1 year | −13.3% | −21.2% | ◎+15.4% |
| Share price, 3 months | −4.7% | ◎+15.3% | +13.0% |
| P/E (trailing)lower = cheaper | — | 35.7x | 77.9x |
| Equity ratio | — | ◎53.1% | 35.9% |
| Share price (close) | ¥1,840.5 | ¥3,690 | ¥2,386 |
◎ marks the best value for each metric. Revenue and profit are from the latest full-year earnings release; share prices are closing-price references; P/E = latest close ÷ trailing EPS. For banks and some other financials, revenue means ordinary income.
| Metric | M3 | JMDC | Medley |
|---|---|---|---|
| Average salary | ◎¥9.31M | ¥8.23M | ¥5.63M |
| Average tenure | 4.1 yrs | ◎4.5 yrs | 3.6 yrs |
| Average age | 34.7 | 39.4 | 33.8 |
| Employees | 704 | 499 | 1,511 |
Average salary is for the reporting (parent) company and is affected by average age and job mix. Holding companies with few employees are left out of the salary comparison.
Close (Oct 30, 2026)
¥1,840.5-13.3% (1Y)
M3 -13.3% over 1Y. Compared: JMDC -21.2%, Medley +15.4%.
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Each line shows the % change from the start of the period. Updated Oct 30, 2026.
M34 segments
JMDC2 segments
Medley3 segments
AAverage annual salary from the securities filings: M3 ¥9.31M, JMDC ¥8.23M, Medley ¥5.63M. M3 pays the most. Averages also depend on staff age and job mix, so check the average age too (M3 34.7, JMDC 39.4, Medley 33.8).
ARevenue in the latest results: M3 ¥351.4B, JMDC ¥50.5B, Medley ¥36.8B. M3 is the largest by revenue at ¥351.4B, followed by JMDC (¥50.5B) and Medley (¥36.8B).
AOperating margins: M3 20.9%, JMDC 20.8%, Medley 5.8%. M3 turns the highest share of sales into operating profit.
AShare price change over the past year (closing prices, for reference): Medley +15.4%, M3 −13.3%, JMDC −21.2%. Medley has risen the most.

Comparing 3 companies (up to 4)
Sources: earnings releases (kessan tanshin), annual securities reports and other public information. Share prices are closing-price references, not real-time. Our data may contain errors; investment decisions are your own responsibility.